Mutation of MET Y1230 as an Acquired Mechanism of Crizotinib Resistance in NSCLC with MET Exon 14 Skipping Letter

Schrock, AB, Lai, A, Ali, SM et al. (2017). Mutation of MET Y1230 as an Acquired Mechanism of Crizotinib Resistance in NSCLC with MET Exon 14 Skipping . JOURNAL OF THORACIC ONCOLOGY, 12(7), e89-e90. 10.1016/j.jtho.2017.02.017

cited authors

  • Schrock, AB; Lai, A; Ali, SM; Miller, VA; Raez, LE

authors

publication date

  • July 1, 2017

published in

Digital Object Identifier (DOI)

start page

  • e89

end page

  • e90

volume

  • 12

issue

  • 7